• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Trending:
  • Kashmir
  • Elections
Sunday, June 21, 2026

Daily Times

Your right to know

  • HOME
  • Latest
  • Iran-Israel war
  • Gilgit Baltistan Election
  • Pakistan
    • Balochistan
    • Gilgit Baltistan
    • Khyber Pakhtunkhwa
    • Punjab
    • Sindh
  • World
  • Editorials & Opinions
    • Editorials
    • Op-Eds
    • Commentary / Insight
    • Perspectives
    • Cartoons
    • Letters to the Editor
    • Featured
    • Blogs
      • Pakistan
      • World
      • Lifestyle
      • Culture
      • Sports
  • Business
  • Sports
  • E-PAPER
    • Lahore
    • Islamabad
    • Karachi

Staff Report

Patients in lurch as life saving drugs vanish from hospitals

Published on: January 25, 2017 1:57 AM

LAHORE: Shortage of life saving drugs has left patients in lurch at government hospitals across the country.

Sources in Health Department Tuesday said that hospitals were facing shortage of medicines to cure nine different diseases, including medicines to cure heart diseases and tuberculosis.

“Similarly, vaccines that are unavailable include varivac, infanrix hexa, havrix, and priorix. Birth-related drugs and hormones that are unavailable include proluton depot injections and profasi injections. Also, epivite is nutritional supplement that is not available in the market and folic acids and steroids are also unavailable. The drugs used to treat infections like fungal, viral, bacterial are also not available,” they added.

“Moreover, in the category of neuro and muscular diseases, drugs that are not available include iodex, feldene, dilantin, papaverine, ritalin, codogesic, napadoc, topamax, neuroaid, di-hydan, optalidon tablets, dorphomine, migram, and notcamid tablets.

The drugs that are unavailable in skin diseases/anti-allergy include clariderm, retin-a, grisovin tablets, minoderm 100mg tablets, avil injections and deufilm gel. Anti-depressant, anti-anxiety/pain relief drugs that are not available in the market include risperdal, zilnox 10mg, stilnox, nalbin injections, pain ease injections and Gelusil.”

Commenting on the issue, Osama Siddiqui, a professor of pharmacology, said: “This is very serious situation and leading to health disaster in the country, while patients are the ultimate sufferers.”

He added that when companies were asked about shortage of medicines, they said they were not getting enough profits and it had become unviable to produce most of these medicines.

He said that the government was not paying heed to the issue. “This is dangerous for patients as they are left in lurch with no support from the authorities concerned,” he said.

Healthcare professionals have shown grave concerns over the situation, saying patients are ultimate sufferers due to the tussle between the government and drug companies.

“Ironically, the government first allowed pharmaceutical companies to enhance price of medicines and then reverted the orders. They said that the rich were importing drugs, however, poor patients were not getting medicines.

Filed Under: Punjab

Submit a Comment




Primary Sidebar




Latest News

Vance praises Pakistan’s role as Iran talks advance

NDMA warns of floods and heavy rains nationwide

George Lucas returns to screen with surprise voice role

Jet fuel cut raises hopes for cheaper air travel

National Assembly approves Rs40.48 trillion grants across key sectors

Pakistan

Vance praises Pakistan’s role as Iran talks advance

NDMA warns of floods and heavy rains nationwide

National Assembly approves Rs40.48 trillion grants across key sectors

PPP picks Amjad Hussain for Gilgit-Baltistan top post

Azma Bukhari orders robust Muharram security arrangements

More Posts from this Category

Business

Iran confirms $6 billion frozen funds release in Qatar deal

National assembly approves Rs4.3 trillion federal grants package

Lawmakers halt telecom bill over property rights concerns

Govt targets $4.5 billion market borrowing to diversify beyond bilateral loans in FY27

Gold prices edge down by Rs 43 per tola

More Posts from this Category

World

Vance praises Pakistan’s role as Iran talks advance

Nine remain critical after deadly Bedford train collision

Iran reaffirms enrichment rights ahead of Switzerland talks

More Posts from this Category




Footer

Home
Lead Stories
Latest News
Editor’s Picks

Culture
Life & Style
Featured
Videos

Editorials
OP-EDS
Commentary
Advertise

Cartoons
Letters
Blogs
Privacy Policy

Contact
Company’s Financials
Investor Information
Terms & Conditions

Facebook
Twitter
Instagram
Youtube

© 2026 Daily Times. All rights reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.